| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
Gene-expression profiles predict survival of patients with lung adenocarcinoma Beer DG, Kardia SLR, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen GA, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JMG, Iannettoni MD, Orringer MB, Hanash S NATURE MEDICINE 8 (8): 816-824 AUG 2002 and the citing papers |
Nodes: 179,
Authors: 1011,
Journals: 96,
Outer References: 6194,
Words: 619
Collection span: 2002 - 2005
View: Overview. Sorted by journal name.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 14 | 7 2003 AMERICAN JOURNAL OF PATHOLOGY 163(5):1985-1995 Shedden KA; Taylor JMG; Giordano TJ; Kuick R; Misek DE; et al. Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework | 1 | 2 |
| 2 | 1 | 58 | 8 2003 AMERICAN JOURNAL OF PATHOLOGY 163(6):2383-2395 Linn SC; West RB; Pollack JR; Zhu S; Hernandez-Boussard T; et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans | 0 | 11 |
| 3 | 1 | 58 | 172 2005 AMERICAN JOURNAL OF PATHOLOGY 166(1):81-92 Dowen SE; Crnogorac-Jurcevic T; Gangeswaran R; Hansen M; Eloranta JJ; et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer | 0 | 0 |
| 4 | 4 | 46 | 70 2004 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 170(2):167-174 Borczuk AC; Shah L; Pearson GDN; Walter KL; Wang LQ; et al. Molecular signatures in biopsy specimens of lung cancer | 0 | 0 |
| 5 | 3 | 25 | 9 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(2):153-156 Rom WN; Tchou-Wong KM Functional genomics in lung cancer and biomarker detection | 0 | 0 |
| 6 | 1 | 15 | 10 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(2):157-162 Powell CA; Spira A; Derti A; DeLisi C; Liu G; et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers | 4 | 11 |
| 7 | 1 | 25 | 11 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(3):S32-S36 Kaminski N Microarray analysis of idiopathic pulmonary fibrosis | 0 | 5 |
| 8 | 4 | 46 | 71 2004 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 31(2):S39-S44 [Anon] Expression analysis in lung cancer - The search for biomarkers | 0 | 0 |
| 9 | 1 | 40 | 72 2004 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 31(2):S72-S75 [Anon] Identifying regulatory networks - Lessons from yeast to humans | 0 | 0 |
| 10 | 2 | 115 | 173 2005 ANNALS OF SURGERY 241(1):16-26 Mocellin S; Provenzano M; Rossi CR; Pilati P; Nitti D; et al. DNA array-based gene profiling - From surgical specimen to the molecular portrait of cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 31 | 73 2004 ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 130(3):295-302 Schmalbach CE; Chepeha DB; Giordano TJ; Rubin MA; Teknos TN; et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma | 0 | 1 |
| 12 | 1 | 40 | 74 2004 BERNOULLI 10(6):1011-1037 Keles S; Van der Laan M; Dudoit S Asymptotically optimal model selection method with right censored outcomes | 0 | 0 |
| 13 | 1 | 29 | 75 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 314(4):1133-1140 Shimoji T; Kanda H; Kitagawa T; Kadota K; Asai R; et al. Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma | 0 | 2 |
| 14 | 2 | 38 | 76 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(4):1088-1096 Daiba A; Inaba N; Ando S; Kajiyama N; Yatsuhashi H; et al. A low-density cDNA microarray with a unique reference RNA: pattern recognition analysis for IFN efficacy prediction to HCV as a model | 0 | 0 |
| 15 | 1 | 47 | 77 2004 BIOINFORMATICS 20(18):3544-3552 Linder R; Dew D; Sudhoff H; Theegarten D; Remberger K; et al. The 'subsequent artificial neural network' (SANN) approach might bring more classificatory power to ANN-based DNA microarray analyses | 0 | 0 |
| 16 | 3 | 32 | 174 2005 BIOINFORMATICS 21(2):171-178 Ein-Dor L; Kela I; Getz G; Givol D; Domany E Outcome signature genes in breast cancer: is there a unique set? | 0 | 0 |
| 17 | 1 | 38 | 1 2002 BIOTECHNIQUES :46-53 Sreekumar A; Chinnaiyan AM Using protein microarrays to study cancer | 0 | 2 |
| 18 | 1 | 35 | 12 2003 BIOTECHNIQUES :22-+ Scharpf R; Garrett ES; Hu J; Parmigiani G Statistical modeling and visualization of molecular profiles in cancer | 0 | 1 |
| 19 | 1 | 95 | 13 2003 BLOOD 102(2):763-771 Ichiba T; Teshima T; Kuick R; Misek DE; Liu C; et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays | 0 | 7 |
| 20 | 1 | 37 | 14 2003 BLOOD 102(5):1849-1856 Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; et al. Identification of a gene expression signature associated with pediatric AML prognosis | 1 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 12 | 15 2003 BMC BIOINFORMATICS 4 O'Neill MC; Song L Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect | 0 | 3 |
| 22 | 2 | 16 | 78 2004 BMC BIOINFORMATICS 5 Jiang HY; Deng YP; Chen HS; Tao L; Sha QY; et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes | 0 | 1 |
| 23 | 1 | 17 | 16 2003 BMC GENOMICS 4 McClintick JN; Jerome RE; Nicholson CR; Crabb DW; Edenberg HJ Reproducibility of oligonucleotide arrays using small samples | 0 | 8 |
| 24 | 2 | 34 | 79 2004 BMC GENOMICS 5 Lopez F; Rougemont J; Loriod B; Bourgeois A; Loi L; et al. Feature extraction and signal processing for nylon DNA microarrays | 0 | 2 |
| 25 | 1 | 23 | 80 2004 BMC GENOMICS 5 Schneider J; Buness A; Huber W; Volz J; Kioschis P; et al. Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments | 0 | 2 |
| 26 | 2 | 29 | 81 2004 CANCER 101(7):1632-1638 Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; et al. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma | 0 | 0 |
| 27 | 1 | 52 | 17 2003 CANCER CELL 3(1):9-15 Celis JE; Gromov P Proteomics in translational cancer research: Toward an integrated approach | 2 | 21 |
| 28 | 1 | 9 | 82 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54:S21-S24 Haraguchi N; Inoue H; Mimori K; Tanaka F; Utsunomiya T; et al. Analysis of gastric cancer with cDNA microarray | 0 | 0 |
| 29 | 1 | 42 | 18 2003 CANCER DETECTION AND PREVENTION 27(4):285-290 Zhong L; Peng XJ; Hidalgo GE; Doherty DE; Stromberg AJ; et al. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients | 0 | 0 |
| 30 | 2 | 28 | 19 2003 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 12(9):905-910 Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R A prognostic test for adenocarcinoma of the lung from gene expression profiling data | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 1 | 54 | 83 2004 CANCER GENETICS AND CYTOGENETICS 149(2):98-106 Kettunen E; Anttila S; Seppanen JK; Karjalainen A; Edgren H; et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer | 0 | 3 |
| 32 | 1 | 27 | 84 2004 CANCER GENETICS AND CYTOGENETICS 154(1):63-66 Selvanayagam ZE; Cheung TH; Wei N; Vittal R; Lo KWK; et al. Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling | 0 | 0 |
| 33 | 1 | 89 | 20 2003 CANCER INVESTIGATION 21(6):937-949 Luo J; Isaacs WB; Trent JM; Duggan DJ Looking beyond morphology: Cancer gene expression profiling using DNA microarrays | 0 | 6 |
| 34 | 1 | 45 | 85 2004 CANCER LETTERS 212(1):83-93 Sun WY; Zhang KT; Zhang XY; Lei WD; Xiao T; et al. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization | 0 | 1 |
| 35 | 1 | 17 | 21 2003 CANCER RESEARCH 63(7):1652-1656 Campa MJ; Wang MZ; Howard B; Fitzgerald MC; Patz EF Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin A as potential molecular targets in non-small cell lung cancer | 1 | 13 |
| 36 | 1 | 74 | 22 2003 CANCER RESEARCH 63(8):1943-1953 Pedersen N; Mortensen S; Sorensen SB; Pedersen MW; Rieneck K; et al. Transcriptional gene expression profiling of small cell lung cancer cells | 2 | 9 |
| 37 | 1 | 54 | 23 2003 CANCER RESEARCH 63(14):4136-4143 Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; et al. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas | 0 | 4 |
| 38 | 1 | 47 | 24 2003 CANCER RESEARCH 63(17):5243-5250 Nishizuka S; Chen ST; Gwadry FG; Alexander J; Major SM; et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling | 4 | 22 |
| 39 | 1 | 38 | 86 2004 CANCER RESEARCH 64(1):196-201 Koh TJ; Field JK; Varro A; Liloglou T; Fielding P; et al. Glycine-extended gastrin promotes the growth of lung cancer | 0 | 1 |
| 40 | 1 | 44 | 87 2004 CANCER RESEARCH 64(4):1255-1265 Meireles SI; Cristo EB; Carvalho AF; Hirata R; Pelosof A; et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 2 | 77 | 88 2004 CANCER RESEARCH 64(11):3814-3822 Rubin MA; Varambally S; Beroukhim R; Tomlins SA; Rhodes DR; et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer | 0 | 3 |
| 42 | 1 | 34 | 89 2004 CANCER RESEARCH 64(11):4040-4048 Dyrskjot L; Kruhoffer M; Thykjaer T; Marcussen N; Jensen JL; et al. Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification | 0 | 0 |
| 43 | 1 | 23 | 90 2004 CANCER RESEARCH 64(16):5564-5569 Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer | 0 | 1 |
| 44 | 1 | 44 | 91 2004 CANCER RESEARCH 64(19):6883-6891 Wei JS; Greer BT; Westermann F; Steinberg SM; Son CG; et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma | 0 | 3 |
| 45 | 1 | 46 | 25 2003 CARCINOGENESIS 24(11):1819-1826 Gariboldi M; Spinola M; Milani S; Pignatiello C; Kadota K; et al. Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice | 0 | 0 |
| 46 | 1 | 41 | 92 2004 CARCINOGENESIS 25(7):1157-1163 Cuezva JM; Chen G; Isidoro A; Misek DE; Hanash SM; et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis | 0 | 0 |
| 47 | 3 | 23 | 93 2004 CHEST 125(5):111S-115S Kaminski N; Krupsky M Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology | 0 | 0 |
| 48 | 1 | 31 | 94 2004 CHEST 125(5):123S-127S Omenn GS Human lung cancer chemoprevention strategies | 0 | 0 |
| 49 | 3 | 73 | 95 2004 CLINICAL BIOCHEMISTRY 37(7):572-578 Robison JE; Perreard L; Bernard PS State of the science: molecular classifications of breast cancer for clinical diagnostics | 0 | 0 |
| 50 | 1 | 45 | 2 2002 CLINICAL CANCER RESEARCH 8(12):3803-3812 Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; et al. RANTES expression is a predictor of survival in stage I lung adenocarcinoma | 4 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 1 | 42 | 26 2003 CLINICAL CANCER RESEARCH 9(7):2605-2612 Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; et al. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis | 0 | 1 |
| 52 | 1 | 25 | 27 2003 CLINICAL CANCER RESEARCH 9(13):4695-4704 Yamagata N; Shyr Y; Yanagisawa K; Edgerton M; Dang TP; et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer | 2 | 5 |
| 53 | 1 | 28 | 28 2003 CLINICAL CANCER RESEARCH 9(15):5486-5492 Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; et al. Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray | 1 | 4 |
| 54 | 1 | 42 | 29 2003 CLINICAL CANCER RESEARCH 9(16):5980-5987 Lim EH; Aggarwal A; Agasthian T; Wong PS; Tan C; et al. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers | 3 | 4 |
| 55 | 1 | 42 | 96 2004 CLINICAL CANCER RESEARCH 10(1):136-143 Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer | 1 | 4 |
| 56 | 1 | 14 | 97 2004 CLINICAL CANCER RESEARCH 10(9):2922-2927 Parmigiani G; Garrett-Mayer ES; Anbazhagan R; Gabrielson E A cross-study comparison of gene expression studies for the molecular classification of lung cancer | 0 | 0 |
| 57 | 4 | 48 | 98 2004 CLINICAL CANCER RESEARCH 10(10):3237-3248 Petty RD; Nicolson MC; Kerr KM; Collie-Duguid E; Murray GI Gene expression profiling in non-small cell lung cancer: From molecular mechanisms to clinical application | 0 | 0 |
| 58 | 1 | 57 | 99 2004 CLINICAL CANCER RESEARCH 10(10):3410-3421 Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; et al. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles | 0 | 1 |
| 59 | 2 | 23 | 100 2004 CLINICAL CANCER RESEARCH 10(11):3745-3754 Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a Randomized trial of continuous hyperfractionated accelerated radiotherapy | 0 | 1 |
| 60 | 1 | 33 | 101 2004 CLINICAL CANCER RESEARCH 10(18):6023-6028 Bianchi F; Hu JT; Pelosi G; Cirincione R; Ferguson M; et al. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA Mmicroarray | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 3 | 44 | 102 2004 CLINICAL CANCER RESEARCH 10(18):6029-6038 Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; et al. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma | 0 | 0 |
| 62 | 2 | 18 | 175 2005 CLINICAL CANCER RESEARCH 11(2):565-572 Dobbin KK; Beer DG; Meyerson M; Yeatman TJ; Gerald WL; et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays | 0 | 0 |
| 63 | 4 | 124 | 103 2004 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 7(3):183-206 Kim AS Clinical impact of gene expression profiling on oncology diagnosis, prognosis, and treatment | 0 | 1 |
| 64 | 1 | 97 | 104 2004 CURRENT CANCER DRUG TARGETS 4(2):111-124 Onyango P The role of emerging genomics and proteomics technologies in cancer drug target discovery | 0 | 1 |
| 65 | 1 | 181 | 30 2003 CURRENT MEDICINAL CHEMISTRY 10(8):691-706 Goessl C Noninvasive molecular detection of cancer - the bench and the bedside | 0 | 6 |
| 66 | 1 | 37 | 31 2003 CURRENT OPINION IN CELL BIOLOGY 15(2):213-220 Ciro M; Bracken AP; Helin K Profiling cancer | 1 | 3 |
| 67 | 9 | 61 | 105 2004 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 7(3):290-303 Muller-Hagen G; Beinert T; Sommer A Aspects of lung cancer gene expression profiling | 0 | 0 |
| 68 | 1 | 27 | 3 2002 CURRENT OPINION IN MOLECULAR THERAPEUTICS 4(6):587-593 Sreekumar A; Chinnaiyan AM Protein microarrays: A powerful tool to study cancer | 0 | 4 |
| 69 | 4 | 52 | 106 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6(6):593-599 Sultmann H; Poustka A Recent advances in transcription profiling of human cancer | 0 | 0 |
| 70 | 2 | 154 | 107 2004 DISEASE MARKERS 20(2):71-85 Vourlekis JS; Szabo E Use of markers for the detection and treatment of lung cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 1 | 17 | 108 2004 DNA AND CELL BIOLOGY 23(10):715-721 Ptitsyn A Class discovery analysis of the lung cancer gene expression data | 0 | 0 |
| 72 | 2 | 61 | 109 2004 DRUG DEVELOPMENT RESEARCH 62(2):124-133 Chin KV; Selvanayagam ZE; Vittal R; Kita T; Kudoh K; et al. Application of expression genomics in drug development and genomic medicine | 0 | 0 |
| 73 | 1 | 41 | 32 2003 DRUG DISCOVERY TODAY 8(8):356-363 Huang Y; Sadee W Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach | 1 | 7 |
| 74 | 3 | 109 | 110 2004 DRUG RESISTANCE UPDATES 7(3):209-218 Mariadason JM; Arango D; Augenlicht LH Customizing chemotherapy for colon cancer: the potential of gene expression profiling | 0 | 0 |
| 75 | 2 | 48 | 33 2003 ENDOCRINE PATHOLOGY 14(2):107-116 Giordano TJ Gene expression profiling of endocrine tumors using DNA microarrays: Progress and promise | 0 | 1 |
| 76 | 1 | 26 | 111 2004 ENDOCRINE-RELATED CANCER 11(2):377-389 Zierhut B; Mechtler K; Gartner W; Daneva T; Base W; et al. Heat shock protein 70 (Hsp70) subtype expression in neuroendocrine tissue and identification of a neuroendocrine tumour-specific Hsp70 truncation | 0 | 0 |
| 77 | 3 | 244 | 112 2004 ENDOCRINE-RELATED CANCER 11(4):659-687 Carter P; Smith L; Ryan M Identification and validation of cell surface antigens for antibody targeting in oncology | 0 | 0 |
| 78 | 1 | 26 | 113 2004 EUROPEAN JOURNAL OF CANCER 40(17):2544-2549 Sausville EA; Holbeck SL Transcription profiling of gene expression in drug discovery and development: the NO experience | 0 | 0 |
| 79 | 2 | 160 | 114 2004 EUROPEAN JOURNAL OF CANCER 40(17):2560-2591 Clarke PA; te Poele R; Workman P Gene expression microarray technologies in the development of new therapeutic agents | 0 | 1 |
| 80 | 3 | 105 | 115 2004 EUROPEAN JOURNAL OF CANCER 40(17):2604-2612 Rapkiewicz AV; Espina V; Petricoin EF; Liotta LA Biomarkers of ovarian tumours | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 5 | 113 | 116 2004 EUROPEAN JOURNAL OF CANCER 40(17):2623-2632 Wulfkuhle J; Espina V; Liotta L; Petricoin E Genomic and proteomic technologies for individualisation and improvement of cancer treatment | 0 | 0 |
| 82 | 1 | 12 | 34 2003 EUROPEAN RESPIRATORY JOURNAL 21(4):565-566 Field JK; Brambilla C Major conceptual change required to improve lung cancer: see a respiratory physician | 0 | 2 |
| 83 | 2 | 200 | 117 2004 EXPERT OPINION ON INVESTIGATIONAL DRUGS 13(6):609-629 Saba N; Khuri F Novel targeted agents in the treatment of lung cancer | 0 | 0 |
| 84 | 1 | 78 | 35 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(1):55-67 Valle RPC; Chavany C; Zhukov TA; Jendoubi M New approaches for biomarker discovery in lung cancer | 0 | 4 |
| 85 | 1 | 84 | 36 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(2):185-200 Macgregor PF Gene expression in cancer: the application of microarrays | 0 | 6 |
| 86 | 1 | 86 | 37 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(5):635-647 Dyrskjot L Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics | 0 | 3 |
| 87 | 1 | 11 | 38 2003 FEBS LETTERS 540(1-3):167-170 Creighton C; Hanash S; Beer D Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas | 2 | 3 |
| 88 | 1 | 38 | 118 2004 GASTROENTEROLOGY 127(2):457-469 Leung SY; Yuen ST; Chu KM; Mathy JA; Li R; et al. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer | 0 | 0 |
| 89 | 1 | 23 | 119 2004 GASTROENTEROLOGY 127(5):S51-S55 Lee JS; Thorgeirsson SS Genome-scale profiling of gene expression in hepatocellular carcinoma: Classification, survival prediction, and identification of therapeutic targets | 0 | 1 |
| 90 | 1 | 53 | 120 2004 GENES CHROMOSOMES & CANCER 41(1):65-79 Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; et al. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 1 | 32 | 39 2003 GENOME BIOLOGY 4(3) Muro S; Takemasa I; Oba S; Matoba R; Ueno N; et al. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data | 0 | 8 |
| 92 | 2 | 22 | 40 2003 GENOME BIOLOGY 4(7) Creighton C; Kuick R; Misek DE; Rickman DS; Brichory FM; et al. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice | 0 | 2 |
| 93 | 1 | 46 | 41 2003 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17(2):377-+ Mariadason JM; Augenlicht LH; Arango D Microarray analysis in the clinical management of cancer | 0 | 2 |
| 94 | 1 | 39 | 121 2004 HEPATOLOGY 40(3):667-676 Lee JS; Chu IS; Heo J; Calvisi DF; Sun ZT; et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling | 0 | 3 |
| 95 | 2 | 34 | 122 2004 HUMAN MOLECULAR GENETICS 13(24):3029-3043 Kakiuchi S; Daigo Y; Ishikawa N; Furukawa C; Tsunoda T; et al. Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839) | 0 | 0 |
| 96 | 1 | 50 | 42 2003 HYPERTENSION 41(1):3-8 Pravenec M; Wallace C; Aitman TJ; Kurtz TW Gene expression profiling in hypertension research - A critical perspective | 0 | 7 |
| 97 | 1 | 29 | 123 2004 INTERNAL MEDICINE JOURNAL 34(9-10):565-569 Thomas DM; Fleming NI; Holloway AJ; Bowtell DDL Molecular medicine: a clinician's primer on microarrays | 0 | 0 |
| 98 | 1 | 21 | 43 2003 INTERNATIONAL JOURNAL OF CANCER 107(2):238-243 Player A; Gillespie J; Fujii T; Fukuoka J; Dracheva T; et al. Identification of TDE2 gene and its expression in non-small cell lung cancer | 0 | 3 |
| 99 | 1 | 62 | 124 2004 INTERNATIONAL JOURNAL OF CANCER 112(1):100-112 Missiaglia E; Blaveri E; Terris B; Wang YH; Costello E; et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis | 0 | 1 |
| 100 | 3 | 30 | 125 2004 INTERNATIONAL JOURNAL OF HEMATOLOGY 80(5):389-394 Mano H Stratification of acute myeloid leukemia based on gene expression profiles | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 1 | 35 | 126 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(7):5059-5065 Arumugam T; Simeone DM; Schmidt AM; Logsdon CD S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) | 0 | 6 |
| 102 | 1 | 34 | 44 2003 JOURNAL OF CLINICAL ONCOLOGY 21(14):2651-2657 Weber WA; Petersen V; Schmidt B; Tyndale-Hines L; Link T; et al. Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use | 0 | 17 |
| 103 | 1 | 44 | 127 2004 JOURNAL OF CLINICAL ONCOLOGY 22(5):811-819 Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction | 0 | 1 |
| 104 | 1 | 49 | 128 2004 JOURNAL OF CLINICAL ONCOLOGY 22(9):1564-1571 Wang YX; Jatkoe T; Zhang Y; Mutch MG; Talantov D; et al. Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer | 0 | 7 |
| 105 | 2 | 65 | 129 2004 JOURNAL OF CLINICAL ONCOLOGY 22(16):3218-3229 Aljada IS; Ramnath N; Donohue K; Harvey S; Brooks JJ; et al. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer | 0 | 1 |
| 106 | 2 | 63 | 130 2004 JOURNAL OF CLINICAL ONCOLOGY 22(22):4575-4583 Lu C; Soria JC; Tang XM; Xu XC; Wang L; et al. Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers | 0 | 0 |
| 107 | 1 | 48 | 131 2004 JOURNAL OF CLINICAL ONCOLOGY 22(23):4648-4658 Spentzos D; Levine DA; Ramoni MF; Joseph M; Gu XS; et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer | 0 | 1 |
| 108 | 1 | 22 | 132 2004 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 23(1):135-141 Kurokawa Y; Matoba R; Nakamori S; Takemasa I; Nagano H; et al. PCR-array gene expression profiling of hepatocellular carcinoma | 2 | 2 |
| 109 | 1 | 25 | 133 2004 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 23(3):521-527 Komori T; Takemasa I; Higuchi H; Yamasaki M; Ikeda M; et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray | 0 | 0 |
| 110 | 2 | 49 | 134 2004 JOURNAL OF HEPATOLOGY 41(2):284-291 Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma | 1 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 3 | 30 | 135 2004 JOURNAL OF PATHOLOGY 202(3):321-329 Chen GA; Wang H; Miller CT; Thomas DG; Gharib TG; et al. Reduced selenium-binding protein I expression is associated with poor outcome in lung adenocarcinomas | 0 | 3 |
| 112 | 1 | 31 | 136 2004 JOURNAL OF PATHOLOGY 203(3):798-807 Ullmann R; Morbini P; Halbwedl I; Bongiovanni M; Gogg-Kammerer M; et al. Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays | 0 | 0 |
| 113 | 2 | 110 | 176 2005 JOURNAL OF PATHOLOGY 205(2):236-247 Dennis JL; Oien KA Hunting the primary: novel strategies for defining the origin of tumours | 0 | 1 |
| 114 | 2 | 33 | 45 2003 JOURNAL OF PEDIATRICS 142(3):235-239 Bates MD The potential of DNA microarrays for the care of children | 0 | 0 |
| 115 | 2 | 66 | 137 2004 JOURNAL OF PROTEOME RESEARCH 3(2):245-252 Chaurand P; Schwartz SA; Caprioli RM Assessing protein patterns in disease using imaging mass spectrometry | 0 | 8 |
| 116 | 2 | 27 | 138 2004 JOURNAL OF SURGICAL RESEARCH 122(1):61-69 Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; et al. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer | 0 | 0 |
| 117 | 1 | 57 | 139 2004 JOURNAL OF SURGICAL RESEARCH 122(2):184-194 Murakawa K; Tada M; Takada M; Tamoto E; Shindoh G; et al. Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data | 0 | 0 |
| 118 | 1 | 25 | 46 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(8):598-605 Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; et al. Using gene expression ratios to predict outcome among patients with mesothelioma | 2 | 14 |
| 119 | 1 | 34 | 47 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(18):1362-1369 Dobbin K; Shih JH; Simon R Questions and answers on design of dual-label microarrays for identifying differentially expressed genes | 0 | 8 |
| 120 | 2 | 28 | 140 2004 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY 127(5):1332-1342 Hoang CD; D'Cunha J; Tawfic SH; Gruessner AC; Kratzke RA; et al. Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 1 | 31 | 48 2003 KLINISCHE PADIATRIE 215(3):135-138 Staege MS; Hattenhorst UE; Neumann I; Hutter C; Foja S; et al. DNA-microarrays as tools for the Identification of tumor specific gene expression profiles: Applications in tumor biology, diagnosis and therapy | 0 | 3 |
| 122 | 1 | 69 | 49 2003 LABORATORY INVESTIGATION 83(3):305-316 Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; et al. DNA arrays in clinical oncology: Promises and challenges | 0 | 11 |
| 123 | 1 | 33 | 50 2003 LANCET 362(9382):433-439 Yanagisawa K; Shyr Y; Xu BGJ; Massion PP; Larsen PH; et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer | 8 | 44 |
| 124 | 1 | 104 | 141 2004 LANCET 363(9426):2076-2083 Cobb JP; O'Keefe GE Injury research in the genomic era | 0 | 0 |
| 125 | 1 | 17 | 177 2005 LANCET 365(9458):488-492 Michiels S; Koscielny S; Hill C Prediction of cancer outcome with microarrays: a multiple random validation strategy | 0 | 0 |
| 126 | 1 | 85 | 51 2003 LANCET ONCOLOGY 4(3):177-185 Lonning PE Study of suboptimum treatment response: lessons from breast cancer | 1 | 6 |
| 127 | 1 | 44 | 52 2003 LANGENBECKS ARCHIVES OF SURGERY 388(2):77-82 Hosch SB; Stoecklein NH; Izbicki JR Molecular markers and staging of early esophageal cancer | 0 | 0 |
| 128 | 1 | 110 | 53 2003 LUNG CANCER 40(2):111-121 Sanchez-Cespedes M Dissecting the genetic alterations involved in lung carcinogenesis | 1 | 4 |
| 129 | 2 | 33 | 142 2004 LUNG CANCER 45:S145-S150 Muller-Tidow C; Diederichs S; Thomas M; Serve H Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer | 0 | 0 |
| 130 | 1 | 17 | 143 2004 LUNG CANCER 46(2):197-204 Blackhall FH; Wigle DA; Jurisica I; Pintilie M; Liu N; et al. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 3 | 29 | 144 2004 LUNG CANCER 46(2):215-226 Yang P; Sun Z; Aubry MC; Kosari F; Bamlet W; et al. Study design considerations in clinical outcome research of lung cancer using microarray analysis | 0 | 0 |
| 132 | 1 | 45 | 54 2003 MOLECULAR & CELLULAR PROTEOMICS 2(2):107-116 Chen G; Wang H; Gharib TG; Huang CC; Thomas DG; et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas | 1 | 7 |
| 133 | 1 | 40 | 145 2004 MOLECULAR CANCER THERAPEUTICS 3(8):993-1001 Holland CM; Saidi SA; Evans AL; Sharkey AM; Latimer JA; et al. Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets | 0 | 0 |
| 134 | 1 | 94 | 146 2004 NATURE BIOTECHNOLOGY 22(5):615-621 Miklos GLG; Maleszka R Microarray reality checks in the context of a complex disease | 1 | 5 |
| 135 | 1 | 50 | 4 2002 NATURE GENETICS 32:533-540 Chung CH; Bernard PS; Perou CM Molecular portraits and the family tree of cancer | 5 | 54 |
| 136 | 1 | 36 | 178 2005 NATURE GENETICS 37(1):48-55 Sweet-Cordero A; Mukherjee S; Subramanian A; You H; Roix JJ; et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis | 0 | 1 |
| 137 | 0 | 45 | 5 2002 NATURE MEDICINE 8(8):816-824 Beer DG; Kardia SLR; Huang CC; Giordano TJ; Levin AM; et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma | 178 | 178 |
| 138 | 1 | 1 | 6 2002 NATURE REVIEWS CANCER 2(8):558-559 Hutchinson E Profiles of lung cancer | 0 | 0 |
| 139 | 2 | 37 | 147 2004 NATURE REVIEWS CANCER 4(8):638-644 Hanash S Opinion - Integrated global profiling of cancer | 0 | 1 |
| 140 | 1 | 46 | 148 2004 NEOPLASIA 6(1):1-6 Rhodes DR; Yu JJ; Shanker K; Deshpande N; Varambally R; et al. ONCOMINE: A cancer microarray database and integrated data-mining platform | 1 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 1 | 24 | 149 2004 NEOPLASIA 6(6):761-767 Blackhall FH; Pintilie M; Wigle DA; Jurisica I; Liu N; et al. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection | 0 | 0 |
| 142 | 1 | 41 | 55 2003 NEUROTOXICOLOGY 24(3):321-332 Vrana KE; Freeman WM; Aschner M Use of microarray technologies in toxicology research | 0 | 8 |
| 143 | 1 | 45 | 150 2004 NEW ENGLAND JOURNAL OF MEDICINE 350(16):1605-1616 Bullinger L; Dohner K; Bair E; Frohling S; Schlenk RF; et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia | 2 | 30 |
| 144 | 1 | 46 | 56 2003 NEW TRENDS IN CANCER FOR THE 21ST CENTURY 532:51-58 Madoz-Gurpide J; Hanash SM Molecular analysis of cancer using DNA and protein microarrays | 0 | 2 |
| 145 | 1 | 43 | 151 2004 NUCLEIC ACIDS RESEARCH 32:W485-W491 Herrero J; Vaquerizas JM; Al-Shahrour F; Conde L; Mateos A; et al. New challenges in gene expression data analysis and the extended GEPAS | 0 | 1 |
| 146 | 1 | 73 | 179 2005 NUCLEIC ACIDS RESEARCH 33(1):409-421 Yap YL; Wong MP; Zhang XW; Hernandez D; Gras R; et al. Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays | 0 | 0 |
| 147 | 1 | 33 | 57 2003 ONCOGENE 22(14):2192-2205 Kikuchi T; Daigo Y; Katagiri T; Tsunoda T; Okada K; et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs | 11 | 37 |
| 148 | 1 | 37 | 58 2003 ONCOGENE 22(39):7950-7957 Miller CT; Chen G; Gharib TG; Wang H; Thomas DG; et al. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas | 0 | 3 |
| 149 | 1 | 123 | 59 2003 ONCOGENE 22(42):6497-6507 Russo G; Zegar C; Giordano A Advantages and limitations of microarray technology in human cancer | 2 | 15 |
| 150 | 1 | 44 | 60 2003 ONCOGENE 22(51):8246-8254 Kartasheva NN; Lenz-Bauer C; Hartmann O; Schafer H; Eilers M; et al. Delta Np73 can modulate the expression of various genes in a p53-independent fashion | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 1 | 102 | 152 2004 ONCOGENE 23(7):1377-1391 Bertucci F; Salas S; Eysteries S; Nasser V; Finetti P; et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters | 2 | 10 |
| 152 | 1 | 30 | 153 2004 ONCOGENE 23(15):2716-2726 Janne PA; Li C; Zhao XJ; Girard L; Chen TH; et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines | 0 | 4 |
| 153 | 1 | 125 | 154 2004 ONCOGENE 23(16):2907-2918 Mosser DD; Morimoto RI Molecular chaperones and the stress of oncogenesis | 0 | 9 |
| 154 | 1 | 36 | 155 2004 ONCOGENE 23(17):3089-3096 Kobayashi K; Nishioka M; Kohno T; Nakamoto M; Maeshima A; et al. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo | 0 | 0 |
| 155 | 2 | 37 | 156 2004 ONCOGENE 23(31):5360-5370 Tomida S; Koshikawa K; Yatabe Y; Harano T; Ogura N; et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 0 | 0 |
| 156 | 1 | 31 | 157 2004 ONCOGENE 23(37):6316-6324 Liu J; Blackhall F; Seiden-Long I; Jurisica I; Navab R; et al. Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis | 0 | 0 |
| 157 | 1 | 29 | 158 2004 ONCOGENE 23(39):6677-6683 Saidi SA; Holland CM; Kreil DP; MacKay DJC; Charnock-Jones DS; et al. Independent component analysis of microarray data in the study of endometrial cancer | 0 | 1 |
| 158 | 2 | 124 | 159 2004 ONCOGENE 23(46):7734-7745 Petroziello J; Yamane A; Westendorf L; Thompson M; McDonagh C; et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer | 0 | 0 |
| 159 | 1 | 32 | 61 2003 ONCOLOGIST 8(3):252-258 Pusztai L; Ayers M; Stec J; Hortobagyi GN Clinical application of cDNA microarrays in oncology | 1 | 9 |
| 160 | 2 | 54 | 160 2004 PATHOLOGY RESEARCH AND PRACTICE 200(2):147-154 Waldburg N; Kahne T; Reisenauer A; Rocken C; Welte T; et al. Clinical proteomics in lung diseases | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 1 | 20 | 62 2003 PHYSICAL REVIEW LETTERS 90(15) Agrawal H; Domany E Potts ferromagnets on coexpressed gene networks: Identifying maximally stable partitions | 0 | 2 |
| 162 | 1 | 25 | 161 2004 PHYSIOLOGICAL GENOMICS 16(3):361-370 Mah N; Thelin A; Lu T; Nikolaus S; Kuhbacher T; et al. A comparison of oligonucleotide and cDNA-based microarray systems | 0 | 4 |
| 163 | 2 | 42 | 162 2004 PHYSIOLOGICAL GENOMICS 18(3):308-315 Mecham BH; Wetmore DZ; Szallasi Z; Sadovsky Y; Kohane I; et al. Increased measurement accuracy for sequence-verified microarray probes | 0 | 0 |
| 164 | 2 | 36 | 163 2004 PLOS BIOLOGY 2(4):511-522 Bair E; Tibshirani R Semi-supervised methods to predict patient survival from gene expression data | 0 | 0 |
| 165 | 1 | 27 | 63 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8418-8423 Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; et al. Repeated observation of breast tumor subtypes in independent gene expression data sets | 8 | 78 |
| 166 | 2 | 26 | 64 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(23):13537-13542 Chen GA; Gharib TG; Wang H; Huang CC; Kuick R; et al. Protein profiles associated with survival in lung adenocarcinoma | 5 | 12 |
| 167 | 1 | 42 | 164 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(3):811-816 Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer | 1 | 14 |
| 168 | 2 | 25 | 165 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(27):10143-10148 Spira A; Beane J; Shah V; Liu G; Schembri F; et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome | 0 | 1 |
| 169 | 2 | 29 | 65 2003 PROTEOMICS 3(4):496-504 Chen G; Gharib TG; Thomas DG; Huang CC; Misek DE; et al. Proteomic analysis of eIF-5A in lung adenocarcinomas | 0 | 5 |
| 170 | 3 | 36 | 166 2004 PROTEOMICS 4(9):2776-2788 Seike M; Kondo T; Fujii K; Yamada T; Gemma A; et al. Proteomic signature of human cancer cells | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 2 | 126 | 66 2003 RESPIRATORY RESEARCH 4(12) Massion PP; Carbone DP The molecular basis of lung cancer: molecular abnormalities and therapeutic implications | 0 | 1 |
| 172 | 1 | 108 | 167 2004 REVUE DES MALADIES RESPIRATOIRES 21(1):93-103 Barlesi F; Doddoli C; Greillier L; Astoul P; Giudicelli R; et al. Prognostic indicators in stage I non-small cell lung cancer | 0 | 1 |
| 173 | 1 | 9 | 67 2003 SCIENTIST :22-24 Lewis R DNA expression profiling: A new lens on cancer - The seeds of spread may be sown early | 0 | 0 |
| 174 | 1 | 140 | 168 2004 SEMINARS IN ONCOLOGY 31(1):4-19 Meyerson M; Franklin WA; Kelley MJ Molecular classification and molecular genetics of human lung cancers | 1 | 4 |
| 175 | 1 | 67 | 169 2004 SEMINARS IN ONCOLOGY 31(1):39-53 Kohn EC; Lu YL; Wang HW; Yu QH; Yu SX; et al. Molecular therapeutics: Promise and challenges | 0 | 1 |
| 176 | 1 | 34 | 68 2003 SWISS MEDICAL WEEKLY 133(3-4):31-38 Joos L; Eryuksel E; Brutsche MH Functional genomics and gene microarrays - the use in research and clinical medicine | 0 | 5 |
| 177 | 1 | 45 | 170 2004 TOXICOLOGY AND APPLIED PHARMACOLOGY 194(2):189-199 Rockett JC; Burczynski ME; Fornace AJ; Herrmann PC; Krawetz SA; et al. Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells | 0 | 1 |
| 178 | 1 | 46 | 69 2003 TRENDS IN CARDIOVASCULAR MEDICINE 13(4):163-168 Patino WD; Mian OY; Shizukuda Y; Hwang PM Current and future applications of SAGE to cardiovascular medicine | 0 | 3 |
| 179 | 2 | 53 | 171 2004 TRENDS IN MOLECULAR MEDICINE 10(3):113-118 Lonning PE Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance | 0 | 3 |
Generated by: HistCite 2004.12.21